What Researchers Did
Researchers reported on a single patient with a severe form of Guillain-Barre Syndrome (GBS) who received hyperbaric oxygen therapy after conventional treatments showed slow progress.
What They Found
A patient with acute motor axonal neuropathy, a variant of GBS, showed no significant improvement with standard therapies until day 5. After starting hyperbaric oxygen therapy, the patient experienced daily gradual improvements. By day 20, the patient was capable of walking slowly without using a walking aid.
What This Means for Canadian Patients
For Canadian patients with severe forms of Guillain-Barre Syndrome, this case suggests that hyperbaric oxygen therapy might offer a way to speed up recovery when standard treatments are slow. While GBS is not a Health Canada-recognized indication for HBOT, this report highlights a potential area for further exploration.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a single case report, this study's findings cannot be applied to all patients with Guillain-Barre Syndrome and require further investigation through larger studies.